Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CFHR2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CFHR2 mRNA | CTD | PMID:20106945 | CFHR2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CFHR2 mRNA | CTD | PMID:26159488 | CFHR2 | Human | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of CFHR2 protein | CTD | PMID:20106945 | CFHR2 | Human | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of CFHR2 mRNA | CTD | PMID:22100608 and PMID:27153756 | CFHR2 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of CFHR2 gene | CTD | PMID:27153756 | CFHR2 | Human | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of CFHR2 mRNA | CTD | PMID:24449571 | CFHR2 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of CFHR2 promoter | CTD | PMID:27901495 | CFHR2 | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CFHR2 mRNA | CTD | PMID:32234424 | CFHR2 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CFHR2 gene] | CTD | PMID:28238834 | CFHR2 | Human | chromium(6+) | increases expression | EXP | | 6480464 | chromium hexavalent ion results in increased expression of CFHR2 protein | CTD | PMID:28596144 | CFHR2 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of CFHR2 mRNA | CTD | PMID:20106945 and PMID:27989131 | CFHR2 | Human | endosulfan | multiple interactions | EXP | | 6480464 | [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CFHR2 mRNA | CTD | PMID:26159488 | CFHR2 | Human | O-methyleugenol | decreases expression | EXP | | 6480464 | methyleugenol results in decreased expression of CFHR2 mRNA | CTD | PMID:32234424 | CFHR2 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CFHR2 mRNA | CTD | PMID:29067470 | CFHR2 | Human | perfluorononanoic acid | decreases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of CFHR2 mRNA | CTD | PMID:32588087 | CFHR2 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of CFHR2 mRNA | CTD | PMID:29301061 | CFHR2 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CFHR2 mRNA | CTD | PMID:29154799 | CFHR2 | Human | zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of CFHR2 mRNA | CTD | PMID:18356318 | CFHR2 | Human | zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of CFHR2 mRNA | CTD | PMID:18356318 | |